1034913

Gregoire Le Gal, M.D. — FEI 3013606145

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ottawa (Canada)

Additional Details

Clinical Investigator (CI)